ID   IMDH_PYRFU              Reviewed;         485 AA.
AC   P42851;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   10-FEB-2021, entry version 137.
DE   RecName: Full=Inosine-5'-monophosphate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMP dehydrogenase {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMPD {ECO:0000255|HAMAP-Rule:MF_01964};
DE            Short=IMPDH {ECO:0000255|HAMAP-Rule:MF_01964};
DE            EC=1.1.1.205 {ECO:0000255|HAMAP-Rule:MF_01964};
GN   Name=guaB {ECO:0000255|HAMAP-Rule:MF_01964}; OrderedLocusNames=PF0285;
OS   Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=186497;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8890736; DOI=10.1016/0378-1119(96)00044-3;
RA   Collart F.R., Osipiuk J., Trent J., Olsen G.J., Huberman E.;
RT   "Cloning, characterization and sequence comparison of the gene coding for
RT   IMP dehydrogenase from Pyrococcus furiosus.";
RL   Gene 174:209-216(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43587 / DSM 3638 / JCM 8422 / Vc1;
RX   PubMed=10430560;
RA   Maeder D.L., Weiss R.B., Dunn D.M., Cherry J.L., Gonzalez J.M.,
RA   DiRuggiero J., Robb F.T.;
RT   "Divergence of the hyperthermophilic archaea Pyrococcus furiosus and P.
RT   horikoshii inferred from complete genomic sequences.";
RL   Genetics 152:1299-1305(1999).
CC   -!- FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to
CC       xanthosine 5'-phosphate (XMP), the first committed and rate-limiting
CC       step in the de novo synthesis of guanine nucleotides, and therefore
CC       plays an important role in the regulation of cell growth.
CC       {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP + NAD(+) = H(+) + NADH + XMP; Xref=Rhea:RHEA:11708,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57464,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:58053;
CC         EC=1.1.1.205; Evidence={ECO:0000255|HAMAP-Rule:MF_01964};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01964};
CC   -!- ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive
CC       inhibitor that prevents formation of the closed enzyme conformation by
CC       binding to the same site as the amobile flap. In contrast, mizoribine
CC       monophosphate (MZP) is a competitive inhibitor that induces the closed
CC       conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor
CC       inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of
CC       bacterial IMPDH. {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP
CC       from IMP: step 1/1. {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_01964}.
CC   -!- SIMILARITY: Belongs to the IMPDH/GMPR family. {ECO:0000255|HAMAP-
CC       Rule:MF_01964}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U08814; AAC44532.1; -; Genomic_DNA.
DR   EMBL; AE009950; AAL80409.1; -; Genomic_DNA.
DR   PIR; JC4998; JC4998.
DR   RefSeq; WP_011011399.1; NC_018092.1.
DR   SMR; P42851; -.
DR   STRING; 186497.PF0285; -.
DR   PRIDE; P42851; -.
DR   EnsemblBacteria; AAL80409; AAL80409; PF0285.
DR   GeneID; 41712074; -.
DR   KEGG; pfu:PF0285; -.
DR   PATRIC; fig|186497.12.peg.297; -.
DR   eggNOG; arCOG00612; Archaea.
DR   HOGENOM; CLU_022552_2_1_2; -.
DR   OMA; SSMGYCG; -.
DR   OrthoDB; 58700at2157; -.
DR   BioCyc; PFUR186497:G1FZR-293-MONOMER; -.
DR   BRENDA; 1.1.1.205; 5243.
DR   UniPathway; UPA00601; UER00295.
DR   Proteomes; UP000001013; Chromosome.
DR   GO; GO:0003938; F:IMP dehydrogenase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd00381; IMPDH; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_01964; IMPDH; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR005990; IMP_DH.
DR   InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS.
DR   InterPro; IPR001093; IMP_DH_GMPRt.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00478; IMPDH; 1.
DR   PIRSF; PIRSF000130; IMPDH; 1.
DR   SMART; SM00116; CBS; 2.
DR   TIGRFAMs; TIGR01302; IMP_dehydrog; 1.
DR   PROSITE; PS51371; CBS; 2.
DR   PROSITE; PS00487; IMP_DH_GMP_RED; 1.
PE   3: Inferred from homology;
KW   CBS domain; GMP biosynthesis; Metal-binding; NAD; Oxidoreductase;
KW   Potassium; Purine biosynthesis; Reference proteome; Repeat.
FT   CHAIN           1..485
FT                   /note="Inosine-5'-monophosphate dehydrogenase"
FT                   /id="PRO_0000093721"
FT   DOMAIN          99..154
FT                   /note="CBS 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   DOMAIN          156..212
FT                   /note="CBS 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   NP_BIND         294..296
FT                   /note="NAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   REGION          334..336
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   REGION          357..358
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   REGION          381..385
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   ACT_SITE        301
FT                   /note="Thioimidate intermediate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   ACT_SITE        397
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           296
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           298
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           301
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           466
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           467
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   METAL           468
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   BINDING         247
FT                   /note="NAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   BINDING         299
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
FT   BINDING         412
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01964"
SQ   SEQUENCE   485 AA;  52900 MW;  BDA60E0D349E5B5B CRC64;
     MGKFVEKLEN AIRGYTFDDV LLIPQPTEVE PKDVDVSTQI TPNVKLNIPI LSAAMDTVTE
     WEMAVAMARE GGLGVIHRNM SIEEQVEQVK RVKRAERFIV EDVITIAPDE TIDYALFLME
     KHGIDGLPVV EEDRVVGIIT KKDIAAREGR TVKELMTREV ITVPESVDVE EALKIMMENR
     IDRLPVVNED GKLVGLITMS DLVARKKYKN AVRNEKGELL VAAAVSPFDL RRAIELDRAG
     VDVIVVDTAH AHNLKAIKAM KEMRQKVSAD FIVGNIANPK AVDDLTFADA VKVGIGPGSI
     CTTRIVAGVG VPQITAIAMV ADRAQEYGLY VIADGGIKYS GDIVKAIAAG ADAVMLGNLL
     AGTKEAPGKE VIINGRKYKQ YRGMGSLGAM MKGGAERYYQ GGYMKTRKFV PEGVEGVVPY
     RGTVSEVLYQ LVGGLKAGMG YVGARNIKEL KEKGEFVIIT SAGLRESHPH DIIITNEAPN
     YPLER
//
